Key Drivers and Strategic Growth in the Thrombocythaemia Myelofibrosis Treatment Market
The Thrombocythaemia Myelofibrosis Treatment Market is on a robust growth trajectory, with projections indicating it will reach USD 4.5 Billion by 2035, up from USD 2.1 Billion in 2024 . This sustained expansion is propelled by a powerful combination of clinical, demographic, and technological drivers. From the rising global prevalence of myeloproliferative neoplasms and the aging...
0 Commentarii 0 Distribuiri 192 Views 0 previzualizare